Background: THAP1 encodes a transcription factor (THAP1) that harbors an atypical zinc finger domain and regulates cell proliferation. An exon 2 insertion/deletion frameshift mutation in THAP1 is responsible for DYT6 dystonia in Amish-Mennonites. Subsequent screening efforts in familial, mainly early-onset, primary dystonia identified additional THAP1 sequence variants in non-Amish subjects.
THAP1 has joined the dystonia family. 1 An exon 2 insertion/deletion frameshift mutation in THAP1 is responsible for DYT6 dystonia in Amish-Mennonites. 1 Identification of a different exon 2 mutation (F81L) in a German family suggested that sequence variants in THAP1 may contribute to the development of dystonia in diverse populations. 1 In 2 follow-up studies, 11 additional sequence variants were identified in familial, mainly earlyonset, primary dystonia. 2, 3 In most neurology subspecialty practices, the majority of patients with dystonia are adults with largely sporadic focal or segmental involvement. Approximately 8% to 27% of these late-onset probands have at least 1 first-degree relative with dystonia. [4] [5] [6] [7] [8] These data suggest the possibility that adult-onset primary dystonia is due, in large part, to sequence variants of low penetrance in a distinct collection of genes. In support of this hypothesis, DYT1, DYT5, DYT6, DYT11, and DYT12 dystonia exhibit variable expressivity and incomplete penetrance. 9 Late-onset DYT1 dystonia usually manifests as hand-forearm dystonia and rarely generalizes. Similarly, patients with DYT11 may develop late-onset hand-forearm or cervical dystonia. However, screening efforts have shown that DYT1 and DYT11 mutations are only rarely associated with adult-onset sporadic dystonia. [10] [11] [12] In contrast to DYT1 and DYT11, DYT6 dystonia commonly affects muscles of the head, neck, and larynx, with relatively less limb involvement. 13, 14 Moreover, in comparison with DYT1, DYT6 dystonia seems to exhibit a later age-of-onset and often remains focal or segmental in distribution. 1, 2, 13, 14 Based on these considerations, we sought to identify THAP1 sequence variants in a large cohort of subjects with primary, mainly adultonset dystonia.
METHODS Standard protocol approvals, registrations, and patient consents. All human studies were performed in accordance with institutional review board guidelines, and all subjects gave informed consent.
Subjects. Subjects with dystonia and neurologically normal controls were acquired from outpatient clinics at participating institutions and support group meetings of the National Spasmodic Dysphonia Association, National Spasmodic Torticollis Association, Benign Essential Blepharospasm Research Foundation, Dystonia/Spasmodic Torticollis, and Dystonia Medical Research Foundation. Subjects acquired at support group meetings were examined by M.S.L. Subjects with Parkinson disease (PD) were recruited from the clinics of M.S.L. and R.F.P. Clinical diagnoses were made by means of history and examination by 1 or more neurologists or neurolaryngologists at each institution. Neurologically normal controls were defined as individuals with no personal or first-degree family history of movement or neurodegenerative disorder. All controls acquired at the University of Tennessee Health Science Center and support group meetings were examined by M.S.L. or R.F.P. Dystonia was classified in accordance with established schemes. 15, 16 Subjects with known DYT1 dystonia were not recruited into our study.
Clinical diagnoses for 1,810 subjects interrogated with highresolution melting (HRM) appear in table 1. Table 1 DNA isolation and mutation analysis. DNA was extracted from peripheral blood leukocytes using a DNA Isolation Kit for Mammalian Blood (Roche, Morristown, NJ). The Or-agene™ DNA Self-Collection Kit (Genotek, Kanata, Ontario, Canada) was used to acquire DNA from family members unable to visit one of the participating clinical sites.
DNA quantity and quality were analyzed with a NanoDrop ND-100 spectrophotometer (NanoDrop Technologies, Wilmington, DE), Quant-iT™ PicoGreen ® dsDNA Assay Kit (Invitrogen, Carlsbad, CA), and agarose gel electrophoresis. Poor-quality samples were rescued by whole genome amplification with a REPLI-g ® Mini Kit (Qiagen, Valencia, CA). Samples that could not be rescued were not used for HRM and do not appear in table 1.
HRM analyses were performed using the LightCycler ® 480 Real-Time PCR system and HRM Master Mix (Roche Applied Science, Indianapolis, IN) in accordance with manufacturer instructions and our laboratory protocol. 12 With Primer3 (frodo.wi.mit.edu), PCR primers were placed on flanking intronic and untranslated regions (UTRs) to encompass the coding regions of the 3 THAP1 exons (table e-1 on the Neurology ® Web site at www.neurology. org). Optimized HRM reactions were performed in 96-well plates using 20 ng of template DNA, 1X HRM Master Mix, 2.5 mM MgCl 2 , and 200 nM of each primer in a 20-L reaction volume. Detailed PCR cycling and HRM conditions are presented in the e-Methods.
All samples were run in duplicate. Using LightCycler ® 480 Gene Scanning Software (Roche Applied Science), melting curves and difference plots were analyzed by 3 investigators (Y.Z., S.G., and M.S.L.) blinded to phenotype. All samples were unambiguously assigned to genotypes by Gene Scanning software. Then, we sequenced samples with shifted melting curves. For sequencing, 5 L of the PCR products were cleaned using ExoSAP-IT ® (United States Biochemical, Cleveland, OH). Then, 1 to 2 L of the purified PCR products were sequenced in the forward and reverse directions using a 3130XL Genetic Analyzer (Applied Biosystems, Foster City, CA). In addition, to evaluate the sensitivity and specificity of HRM, all 3 THAP1 exons were sequenced in 200 neurologically normal controls and 200 subjects with dystonia.
Statistics. The Fisher exact test was used to evaluate association of the c.71ϩ9CϾT sequence variant with dystonia.
In silico analyses. PMUT and PolyPhen were used to predict the pathologic character of single amino acid mutations. PMUT (mmb2.pcb.ub.es:8080/PMut) is a Web-based tool used for the annotation of pathologic changes in proteins. 17 PMUT is based on the use of neural networks trained to detect pathologic missense mutations and has shown a success rate of greater than 80%. PMUT final output includes a pathogenicity prediction along with a confidence index ranging from 0 (low) to 9 (high). PolyPhen (genetics.bwh.harvard.edu/pph) predicts the possible impact of an amino acid substitution on the function of a human protein based on empirical rules applied to the amino acid sequence, phylogenetic profile scores, and calculation of structural parameters. 18 PolyPhen output includes position-specific independent counts scores. The Kyte and Doolittle hydrophobicity scale was also used for analysis of individual amino acid changes. 19 Protein sequence alignment was performed with ClustalW2 (www.ebi.ac.uk/Tools/clustalw2/). The mean age at onset was 48 years and ranged from 8 to 69 years. All but 2 subjects had late-onset (Ͼ20 years) dystonia. Nine non-Jewish Caucasian subjects from 6 families were found to harbor unique missense mutations in conserved regions of THAP1 (G9C, D17G, F132S, I149T, A166T, and Q187K). Families A, B, and C have a strong family history of dystonia ( figure  3 ). Based on in silico analysis with PMUT, 5 of 6 variants were predicted to be pathologic. Although PMUT classified the A166T variant as neutral, the reliability of this call was 0. PolyPhen predicted that 4 of these 6 variants were either possibly or probably damaging.
RESULTS
In family A, the proband, a 61-year-old woman (family A [II-2], figure 3 ), first noted difficulty writing at age 8 years. Her hand-forearm dystonia persisted into her adult years and has remained task specific. Cervical and jaw-opening masticatory dystonia became manifest at ages 35 and 60 years, respectively. She has shown consistent benefit from injections of botulinum toxin type A for treatment of her cervical and masticatory dystonia. Her mother (deceased) reportedly had childhood-onset unilateral hand tremor and writer's cramp. The proband has 2 sisters and 1 brother. Her brother has writer's cramp. One of the proband's 2 daughters harbors the c.25GϾT variant but is asymptomatic at age 32 years. The c.25GϾT missense mutation in exon 1 of THAP1 leads to substitution of glycine with a hydrophobic cysteine (G9C) residue in the highly conserved THAP domain of THAP1 ( figure 2C) .
In family B, the proband, a 63-year-old man (family B [II-1], figure 3) , has a 9-year history of slowly progressive left leg and truncal dystonia. On neurologic examination, mild right arm dystonia was noted, particularly during ambulation. The c.446TϾC sequence variant found in this subject leads to substitution of a strongly hydrophobic isoleucine residue with a threonine (I149T) in the nuclear localization signal domain of THAP1 ( figure  2C ). The proband's father was diagnosed with cervical dystonia, allegedly after a neck injury, and died at age 58 years from suicide in the setting of significant disability from long-standing cervical dystonia. The proband also has a 50-year-old sister with cervical dystonia (II-4, figure 3 ) who harbors the same c.446TϾC sequence variant. By report, none of their children exhibit dystonia. However, these and other family members were not accessible for neurologic examination and acquisition of DNA.
In family C, the proband, a 71-year-old woman (family C [III-1], figure 3 ), had onset of cervical dystonia at age 53 years. Her sequence variant is located at the C terminus of THAP1 (c.559CϾA) and leads to replacement of glutamine with a lysine residue (Q187K) in the coiled-coil domain of THAP1. A 60-year-old sister, who was unavailable for examination, reportedly has a diagnosis of reflex sympathetic dystrophy with bilateral limb pain but no confirmed diagnosis of dystonia. The proband's parents are deceased and had no reported signs of dystonia at the time of their deaths. The proband's maternal grandfather had probable cervical dystonia with abnormal neck posturing, reportedly similar to the proband's, although he was never formally diagnosed with dystonia. One of the proband's cousins (family C [III-4], figure 3 ) is now 51 years old and has had cervical dystonia for approximately 10 years.
Missense mutations were detected in 3 additional subjects in our cohort. Subject D-1378 with a c.50AϾG (p.D17G) sequence variant is a 57-yearold woman with cervical dystonia that became apparent at age 43 years. Injections of botulinum toxin type A over a period of 8 years have been associated with moderate control of pain and abnormal posturing. She has 2 brothers who are reportedly normal, although the older brother experienced a prolonged episode of atraumatic wry neck during his college years. Subject E-6144 with laryngeal dystonia (adductor subtype) harbors a c.395TϾC (p.F132S) sequence variant. She has shown consistently excellent results with injections of botulinum toxin type A into her thyroarytenoid muscles. There is no reported dystonia in her family.
Subject F-6224 with a c.496GϾA (p.A166T) sequence variant also has adductor laryngeal dystonia. The A166T variant is localized to the coiled-coil domain of THAP1. This subject's dystonia has responded well to injections of botulinum toxin type A. Her maternal grandmother had an undiagnosed late-onset parkinsonism syndrome. She has 2 siblings and 3 children, all neurologically normal by report.
Three additional sequence variants were identified in 11 non-Jewish Caucasian subjects. None of these variants had been reported in available databases (www.hgvs.org/dblist/ccent.html). A c.-42CϾT sequence variant in the 5ЈUTR region of THAP1 was found in 2 female subjects, one with blepharospasm and the other with laryngeal dystonia (adductor subtype). A synonymous exon 1 sequence variant (c.57CϾT) was identified in a subject with segmental craniocervical dystonia that included laryngeal dystonia (adductor subtype), blepharospasm, and lower facial dystonia. In 8 non-Jewish Caucasian subjects, a c.71ϩ9CϾA sequence variant was found in a conserved region of intron 1, adjacent to the consensus 5Ј splice site ( figure 2B) .
The c.71ϩ9CϾA variant was found in cases of blepharospasm, cervical dystonia, masticatory dystonia, and laryngeal dystonia (table 2). In addition, 1 putatively normal control subject harbored this se- ; RK, magenta (basic); STYHCNGQ, green (hydroxyl ϩ amine ϩ basic ϩ Q). ClustalW2 generates the following symbols denoting the degree of conservation observed in each column: asterisk (*) means that residues in that column are identical in all sequences, period (.) means that conserved substitutions have been observed, and colon (:) means that semiconserved substitutions are observed. Sequence variants are highlighted. quence variant. Subject K-1158 had jaw-opening masticatory dystonia that has responded to injections of botulinum toxin type A into the lateral pterygoid muscles. Both subjects with laryngeal dystonia had the adductor subtype. Control subject (Q-1425) was reexamined and interviewed by M.S.L. after discovery of her THAP1 sequence variant. She then presented the history of 2 seizures, possibly febrile, between ages 6 months and 3 years and 3 possible generalized seizures occurring between ages 20 and 30 years. She was prophylactically treated with phenytoin for 5 years. Over the past 1.5 years, she has experienced trismus, possibly triggered by placement of a molar crown. On examination, spontaneous and volitional masticatory, facial, and lingual movements appeared normal. There is no history of dystonia in her 3 children, 2 siblings, or parents. A 1-tailed Fisher exact test failed to confirm nonrandom associations between phenotype (dystonia, normal) and the presence of the c.71ϩ9CϾA intron 1 variant ( p ϭ 0.198).
DISCUSSION
In 1997, the DYT6 locus was mapped to chromosome 8 in 2 large Mennonite families with mainly early-onset, predominantly cranialcervical dystonia. 20 With additional family members, the DYT6 gene locus was narrowed to a 23-cM region on chromosome 8q21-22. 14 Finally, in 2009, 2 distinct THAP1 mutations were identified in 5 DYT6 families. 1 Indicative of a founder effect, 4 Amish-Mennonite families harbored the same F45fs73X protein variant. Another family, of German origin, was found to have a c.241TϾC (p.F81L) sequence variant.
In a follow-up study from the same laboratory, 36 non-DYT1 multiplex families in which at least 1 person had nonfocal involvement before age 22 years were screened for THAP1 sequence variants. 2 Eight families had novel THAP1 sequence variants. 2 Among the 48 affected subjects from 14 families described in their 2 reports, females (n ϭ 29) outnumbered males (n ϭ 19), and all but 3 subjects had childhood or adolescent onset. The median age at onset was 13 years. The spectrum of anatomical involvement was broad and included generalized dystonia (n ϭ 22), segmental dystonia (n ϭ 16), multifocal dystonia (n ϭ 5), and focal dystonia (n ϭ 5). Most subjects had limb onset (33/48). The most common sites of anatomical involvement on examination were arm (92%), cranial (77%), and laryngeal (67%). In another follow-up study, 160 subjects with dystonia (early-onset, generalized, positive family history, facial or laryngeal) were screened for THAP1 sequence variants, and 2 novel truncating deletion mutations were identified in 2 subjects with early-onset generalized dystonia with laryngeal involvement. 3 In contrast to previous studies, our cohort mainly consisted of late-onset focal cases with major concentrations of laryngeal (41%, 460/1,114) and cervical (28%, 315/1,114) dystonia, and the majority of sequence variants were identified in these groups of subjects. THAP1 encodes a 213 residue transcription factor that contains a DNA sequence-specific zincdependent THAP domain (1-81aa), a proline-rich region, a nuclear localization signal (146 -162aa), and a coiled-coil domain (figure 2). 21, 22 The THAP domain is highly conserved across species (figure 2). THAP1 plays an important role in transcriptional regulation in the context of cell proliferation and pRb/E2F cell cycle pathways. THAP1 expression is central to endothelial cell proliferation during angiogenesis. 23 Other THAP zinc fingers, including human THAP2 and THAP3, share structural homology but do not recognize the same DNA target sequence. THAP1 localizes to promyelocytic leukemia nuclear bodies with the proapoptotic leucinezipper protein Par-4 and potentiates tumor necrosis factor ␣-induced apoptosis. 24 Three sequence variants identified in our study, along with 8 of 12 previously reported variants, are located in the THAP domain of THAP1. Using a gel-shift assay, the F81L missense mutation in the THAP domain of THAP1 was shown to reduce binding affinity of THAP1 to target DNA. 1 Other THAP domain missense variants are likely to produce similar effects on DNA binding. In contrast, the c.57CϾT (p.P19P) sequence variant in subject I-7011 could affect premessenger RNA splicing accuracy or efficiency leading to altered levels of splice variants. 25 Alternatively, the p.P19P variant is simply a rare polymorphism and not causally associated with the appearance of dystonia. The intron 1 (c.71ϩ9CϾA) and 5ЈUTR (c.-42CϾT) sequence variants described herein could also exerts effects on splicing fidelity or expression levels. In this regard, both underexpression and overexpression of THAP1 may be deleterious. 23 In our study, single amino acid substitutions (p.F132S, p.I149T, p.A166T, and p.Q187K) outside the THAP domain of THAP1 were also found to be associated with 1 case of late-onset generalized dystonia and 4 cases of late-onset focal dystonia (2 cervical dystonia and 2 laryngeal dystonia). In contrast, the 3 previously published variants located in the C-terminal half of THAP1 are predicted to cause protein truncation and were associated with generalized or segmental dystonia. 2, 3 When combined with data from previous publications, one may speculate that nontruncating sequence variants outside the THAP domain of THAP1 are more likely to be associated with later onset and more restricted anatomical involvement.
Our study has shown that a heterogeneous collection of THAP1 sequence variants may be causally associated with primary dystonia. However, it must be emphasized that the molecular pathogenicity of each variant has not been established. Variable expressivity in age at onset and anatomical distribution was found in individual families. Given that most of our subjects had sporadic dystonia, many THAP1 sequence variants may show low penetrance. Although we found HRM to be an efficient tool for highthroughput screening, HRM does have limitations and may not detect certain homozygous variants or large insertions and deletions. 26 Therefore, the frequency of THAP1 sequence variants reported herein may be an underestimate.
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